Research Paper Volume 13, Issue 23 pp 25453—25465

A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients


Figure 4. Internal validation of the risk model for GC prognosis. (A, B) The RiskScore and overall survival rate of each patient in the low- and high-risk group. (C) High-risk patients had shorter overall survival than low-risk patients. (D) Univariate and (E) multivariate Cox risk ratio analysis revealed that the risk model could predict GC prognosis independently. (FH) The Wilcoxon signed-rank test showed that patients with high RiskScore often yielded late clinical stages, and the results were visualized in heatmaps and boxplots.